New high blood pressure drug shows early promise in small study
NCT ID NCT06780033
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This early-stage study tested a single injection of a new drug called ART101 in adults with high blood pressure. The main goal was to check if the drug is safe and how the body handles it. Only one person took part before the study was stopped, so results are very limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research Central
Adelaide, South Australia, 5000, Australia
-
CMAX Clinical Research Fusion
Norwood, South Australia, 5067, Australia
-
University of Sunshine Coast
Morayfield, Queensland, 4506, Australia
Conditions
Explore the condition pages connected to this study.